Is the medication available as a 4 mg tablet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Sim, galantamina está disponível em comprimido de 4 mg

A galantamina, um inibidor da colinesterase usado no tratamento da doença de Alzheimer, está disponível em comprimidos de 4 mg. 1

Formulação e Dosagem Inicial

A galantamina é apresentada em comprimidos, e a dose inicial recomendada é de 4 mg duas vezes ao dia, administrada com as refeições da manhã e da noite 1. Esta formulação de 4 mg permite:

  • Titulação gradual: Após quatro semanas, a dose é aumentada para 8 mg duas vezes ao dia
  • Individualização posterior: Um aumento para 12 mg duas vezes ao dia pode ser considerado com base na avaliação do benefício clínico e tolerabilidade individual 1

Considerações Práticas

Administração

  • Os comprimidos devem ser tomados com as refeições para minimizar efeitos adversos gastrointestinais (náusea, vômito e diarreia) 1
  • A titulação gradual da dose é essencial para melhorar a tolerabilidade

Eficácia

Estudos demonstraram melhora dos desfechos cognitivos e funcionais, bem como dos sintomas comportamentais, com doses mais altas de galantamina em comparação com placebo 1

Advertência sobre Manipulação de Comprimidos

Embora o comprimido de 4 mg esteja disponível, evite partir comprimidos quando possível 2, 3. Se a divisão for inevitável, use um dispositivo de corte preciso, pois a divisão manual pode resultar em variação de conteúdo de até 21,3% 2, o que é particularmente problemático para medicamentos com janela terapêutica estreita.

References

Research

Accuracy of tablet splitting: Comparison study between hand splitting and tablet cutter.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2014

Related Questions

Can I take two 120 mg extended‑release tablets instead of one 240 mg tablet?
Should a 1.1 cm ovarian follicle be followed up with repeat ultrasound?
How should I manage a 10-month-old infant with a rectal temperature of 100.6 °F and two episodes of vomiting?
What is the recommended evaluation and management for a 10-year-old male with pubic pain, intermittent dysuria for 2–3 months, decreased appetite, and urine specific gravity of 1.015?
How should a 10-year-old boy with two episodes of diarrhea, mild abdominal pain, and no fever be managed?
Is the dosing regimen of 10 sublingual drops taken up to three times daily, about 30 minutes before or after meals, appropriate for an adult patient with cerebral palsy?
In what dosage forms and routes is dehydroepiandrosterone (DHEA) available?
What would a treatment plan look like for a patient with moderate lower‑leg edema?
Which urine laboratory tests should be ordered to evaluate acute kidney injury?
What are the recommended dosage, contraindications, and safety precautions for tiocolchicoside?
What is the appropriate history and physical examination for a 55-year-old male presenting to a cardiac clinic with intermittent substernal chest pressure radiating to the left arm, associated shortness of breath, elevated blood pressure (stage 2 hypertension), normal heart rate, hypertension, hyperlipidemia, type 2 diabetes mellitus, former smoker (20‑pack‑year history, quit 3 years ago), and a family history of premature myocardial infarction?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.